Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
暂无分享,去创建一个
R. Attou | P. Honore | D. De Bels | A. Gallerani | S. Redant | L. Kugener
[1] T. Uyeki,et al. Influenza virus-related critical illness: prevention, diagnosis, treatment , 2019, Critical Care.
[2] Robert Witcher,et al. Pharmacokinetics of Peramivir in an Adolescent Patient Receiving Continuous Venovenous Hemodiafiltration. , 2017, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[3] C. Ghossein,et al. Pharmacokinetic Assessment of Peramivir in a Hospitalized Adult Undergoing Continuous Venovenous Hemofiltration , 2011, The Annals of pharmacotherapy.
[4] J. Donauer,et al. Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage. , 1999, Kidney international. Supplement.
[5] Michael E. Winter,et al. Basic Clinical Pharmacokinetics , 1980 .